Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

Last Close
Jul 17 12:01PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-10.32 Insider Own5.94% Shs Outstand3.40M Perf Week14.64%
Market Cap9.59M Forward P/E- EPS next Y-3.02 Insider Trans0.00% Shs Float3.19M Perf Month25.34%
Income-15.64M PEG- EPS next Q-1.05 Inst Own7.81% Short Float3.07% Perf Quarter4.45%
Sales13.36M P/S0.72 EPS this Y62.84% Inst Trans-4.96% Short Ratio1.57 Perf Half Y-60.61%
Book/sh0.21 P/B13.23 EPS next Y27.05% ROA-108.24% Short Interest0.10M Perf Year-63.94%
Cash/sh0.77 P/C3.67 EPS next 5Y- ROE-413.02% 52W Range1.91 - 48.79 Perf YTD-77.33%
Dividend Est.- P/FCF- EPS past 5Y3.00% ROI-789.65% 52W High-94.22% Beta7.71
Dividend TTM- Quick Ratio0.45 Sales past 5Y45.07% Gross Margin54.46% 52W Low47.65% ATR (14)0.23
Dividend Ex-Date- Current Ratio0.45 EPS Y/Y TTM55.07% Oper. Margin-120.29% RSI (14)63.05 Volatility12.69% 10.26%
Employees114 Debt/Eq3.24 Sales Y/Y TTM-17.70% Profit Margin-117.06% Recom1.00 Target Price6.40
Option/ShortNo / Yes LT Debt/Eq2.41 EPS Q/Q5.17% Payout- Rel Volume0.76 Prev Close2.88
Sales Surprise0.26% EPS Surprise-38.72% Sales Q/Q-11.36% EarningsMay 14 AMC Avg Volume62.56K Price2.82
SMA2018.00% SMA5022.52% SMA200-48.52% Trades Volume19,907 Change-2.08%
Jul-01-24 12:33PM
Jun-27-24 07:30AM
Jun-12-24 07:30AM
May-20-24 01:04PM
May-15-24 01:01PM
07:29AM Loading…
May-14-24 04:05PM
Apr-09-24 02:45PM
Apr-01-24 12:53PM
Mar-28-24 08:53PM
12:39PM Loading…
Feb-22-24 12:39PM
Feb-15-24 08:00AM
Feb-12-24 09:24AM
Feb-06-24 07:30AM
Jan-08-24 07:30AM
Dec-11-23 07:30AM
Nov-30-23 08:51AM
Nov-29-23 01:04PM
Nov-14-23 04:05PM
Nov-09-23 04:30PM
01:51PM Loading…
Nov-03-23 01:51PM
Nov-02-23 05:00PM
Oct-31-23 08:00AM
Oct-26-23 07:30AM
Oct-24-23 07:30AM
Oct-12-23 08:50AM
Oct-11-23 01:47PM
Oct-05-23 07:30AM
Oct-04-23 07:30AM
Oct-02-23 07:30AM
Aug-23-23 09:55AM
Aug-16-23 04:05PM
Aug-14-23 05:06PM
Aug-10-23 08:31PM
Jun-15-23 12:55PM
Jun-13-23 08:50AM
Jun-10-23 04:31PM
Jun-09-23 01:04PM
Jun-08-23 05:25PM
Jun-06-23 04:30PM
May-16-23 01:19PM
May-09-23 07:30AM
May-01-23 04:09PM
Apr-05-23 06:36AM
Apr-04-23 12:30PM
Mar-30-23 04:05PM
Mar-08-23 07:30AM
Mar-01-23 07:30AM
Feb-21-23 04:05PM
Jan-27-23 07:05AM
Jan-20-23 07:30AM
Jan-09-23 04:45PM
Jan-05-23 08:10AM
Jan-04-23 07:30AM
Dec-20-22 04:15PM
Dec-16-22 07:30AM
Dec-15-22 07:30AM
Nov-28-22 04:47PM
Nov-27-22 07:49AM
Nov-22-22 07:30AM
Aug-26-22 07:30AM
Aug-22-22 04:05PM
Aug-15-22 07:30AM
Aug-09-22 08:00AM
Jul-14-22 08:00AM
Jun-29-22 08:00AM
Jun-14-22 08:30AM
May-26-22 08:00AM
May-21-22 08:35AM
May-16-22 04:05PM
Apr-28-22 07:30AM
Apr-26-22 08:26AM
Mar-31-22 04:05PM
Mar-08-22 09:11AM
Mar-03-22 08:00AM
Mar-02-22 08:00AM
Feb-24-22 08:00AM
Jan-27-22 07:30AM
Jan-19-22 01:27PM
Dec-14-21 01:11PM
Vivos Therapeutics, Inc. is a medical technology company which engages in the development and commercialization of treatment alternatives for patients with sleep disordered breathing (SDB). Its solutions are also offered for patients with mild-to-moderate obstructive sleep apnea (OSA). The company was founded by Gurdev Dave Singh, Susan McCullough, RaeAnn Byrnes, Todd Huntsman, and R. Kirk Huntsman on July 7, 2016 and is headquartered in Littleton, CO.